Abstract:Chronic low-grade inflammation is a central component in the pathogenesis of obesity-related expansion of adipose tissue and complications in other metabolic tissues. Five different signaling pathways are defined as dominant determinants of adipose tissue inflammation: These are increased circulating endotoxin due to dysregulation in the microbiota-gut-brain axis, systemic oxidative stress, macrophage accumulation, and adipocyte death. Finally, the nucleotide-binding and oligomerization domain (NOD) leucine-rich repeat family pyrin domain-containing 3 (NLRP3) inflammasome pathway is noted to be a key regulator of metabolic inflammation. The NLRP3 inflammasome and associated metabolic inflammation play an important role in the relationships among fatty acids and obesity. Several highly active molecules, including primarily leptin, resistin, adiponectin, visfatin, and classical cytokines, are abundantly released from adipocytes. The most important cytokines that are released by inflammatory cells infiltrating obese adipose tissue are tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), monocyte chemoattractant protein 1 (MCP-1) (CCL-2), and IL-1. All these molecules mentioned above act on immune cells, causing local and then general inflammation. Three metabolic pathways are noteworthy in the development of adipose tissue inflammation: toll-like receptor 4 (TLR4)/phosphatidylinositol-3'-kinase (PI3K)/Protein kinase B (Akt) signaling pathway, endoplasmic reticulum (ER) stress-derived unfolded protein response (UPR), and inhibitor of nuclear factor kappa-B kinase beta (IKKβ)-nuclear factor kappa B (NF-κB) pathway. In fact, adipose tissue inflammation is an adaptive response that contributes to a visceral depot barrier that effectively filters gut-derived endotoxin. Excessive fatty acid release worsens adipose tissue inflammation and contributes to insulin resistance. However, suppression of adipose inflammation in obesity with anti-inflammatory drugs is not a rational solution and paradoxically promotes insulin resistance, despite beneficial effects on weight gain. Inflammatory pathways in adipocytes are indeed indispensable for maintaining systemic insulin sensitivity. Cannabinoid type 1 receptor (CB1R) is important in obesity-induced pro-inflammatory response; however, blockade of CB1R, contrary to anti-inflammatory drugs, breaks the links between insulin resistance and adipose tissue inflammation. Obesity, however, could be decreased by improving leptin signaling, white adipose tissue browning, gut microbiota interactions, and alleviating inflammation. Furthermore, capsaicin synthesized by chilies is thought to be a new and promising therapeutic option in obesity, as it prevents metabolic endotoxemia and systemic chronic low-grade inflammation caused by high-fat diet.

The regulatory role of eosinophils in adipose tissue depends on autophagy

Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis

Eosinophils Regulate Intra-Adipose Axonal Plasticity

Eosinophil biology from the standpoint of metabolism: implications for metabolic disorders and asthma

Eosinophils prevent diet-induced airway hyperresponsiveness in mice on a high-fat diet

Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma

Eosinophils Reduce Chronic Inflammation In Adipose Tissue By Secreting Th2 Cytokines And Promoting M2 Macrophages Polarization

Obesity-associated Inflammation Triggers an Autophagy–lysosomal Response in Adipocytes and Causes Degradation of Perilipin 1

Reduced Endoplasmic Reticulum Stress-Mediated Autophagy is Required for Leptin Alleviating Inflammation in Adipose Tissue

Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance

Paracrine Regulation of Adipose Tissue Macrophages by Their Neighbors in the Microenvironment of Obese Adipose Tissue

Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat.

Erythropoietin Signaling: A Novel Regulator of White Adipose Tissue Inflammation During Diet-Induced Obesity

Immunomodulatory leptin receptor+ sympathetic perineurial barrier cells protect against obesity by facilitating brown adipose tissue thermogenesis

Reappraisal of Adipose Tissue Inflammation in Obesity

Autophagy acts as a brake on obesity-related fibrosis by controlling purine nucleoside signalling

Harnessing the crosstalk of adipocytes, autophagy, and immune cells for immunotherapy in obesity

Ablation of Siglec-E enhances adipose tissue inflammation through CXCR3 activation and induces monocytic myeloid-derived suppressor cells

Role of Innate and Adaptive Immunity in Obesity-Associated Metabolic Disease

EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance

Adipose tissue lymphocytes and obesity